http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 290 reviews. 290 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Mymox

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only. You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Mymox uses and description

Sort by popularity
Mymox - Used for: Treating infections caused by certain bacteria. It is also used with other medicines to treat Helicobacter pylori infection and ulcers of the small intestines.

Mymox is a penicillin antibiotic. It works by killing sensitive bacteria.

Pharmacology: Inhibits bacterial cell wall mucopeptide synthesis.

Indication: Treatment of ear, nose, throat, GU, skin and skin structure, lower respiratory tract, and acute uncomplicated gonorrhea infections caused by susceptible strains of specific organisms. In combination with clarithromycin and/or lansoprazole for the eradication of H. pylori.

Moxatag

Treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes.

Unlabeled Uses

Treatment of acute otitis media in children.

Antibiotic of group semisynthetic penicillins a wide spectrum of action. It is a 4-hydroxyl analog of ampicillin. It has bactericidal action. Mymox is active against aerobic gram-positive bacteria: Staphylococcus spp. (except strains producing penicillinase), Streptococcus spp; aerobic gram-negative bacteria: Neisseria Gonorrhoeae, Neisseria Meningitidis, Escherichia Coli, Shigella spp., Salmonella spp., Klebsiella spp.

Microorganisms producing penicillinase is resistant to amoxicillin.

In combination with metronidazole is active against Helicobacter Pylori. It is believed that inhibits the development of Mymox resistance of Helicobacter pylori to metronidazole.

There is a cross-resistance between amoxycillin and ampicillin.

The spectrum of antibacterial action while expanding the application of Mymox and beta-lactamase inhibitor clavulanic acid. This combination increased the activity of Mymox against Bacteroides spp., Legionella spp., Nocardia spp., Pseudomonas (Burkholderia) Pseudomallei. However, Pseudomonas Aeruginosa, Serratia Marcescens, and many other gram-bacteria are resistant.

Mymox is a moderate-spectrum antibiotic active against a wide range of Gram-positive, and a limited range of Gram-negative organisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other beta-lactam antibiotics. Mymox is susceptible to degradation by β-lactamase-producing bacteria, and so may be given with clavulanic acid to increase its susceptability. The incidence of β-lactamase-producing resistant organisms, including E. coli, appears to be increasing. Mymox is sometimes combined with clavulanic acid, a β-lactamase inhibitor, to increase the spectrum of action against Gram-negative organisms, and to overcome bacterial antibiotic resistance mediated through β-lactamase production.

Mymox belongs to a group of antibiotics called penicillins. It works by interfering with the ability of bacteria to produce cell walls. The cell wall of the bacteria protects cells from entering the xenogenic substances inside the cells and stop the content of bacteria cell from leaking away. Mymox inhibits the production of transpeptidase(enzyme that is important in biosynthesis of peptidoglycan). Peptidoglycan is essential component of the bacteria that substantiates the cells walls.

Mymox is effective against aerobic Gram-positive bacteria: Staphylococcus spp, Streptococcus spp and aerobic Gram-negative bacteria: Clostridium tetani, Clostridium welchii, Neisseria gonorrhoeae, Neisseria meningitidis, Bacillus anthracis, Listeria monocytogenes, Helicobacter pylori, Klebsiella spp.. Amoxicilin is less effective against: Enterococcus faecalis, Escherichia coli, Proteus mirabilis, Salmonella typhi, Shigella sonnei, Vibrio cholerae.

Bacteria that produce b-lactamase are resistant to the preparation.

Indications:

  • Upper respiratory system infection (nasal passages, sinuses or throat : sinusitis, pharyngitis, laryngitis, tonsillitis)
  • Bacterial infection of the respiratory system (chronic and acute bronchitis, pneumonia)
  • Bacterial infections of the abdomen (peritonitis)
  • Urinary tract or kidneys infections (pyelonephritis)
  • Middle ear infections
  • Skin and soft tissue diseases caused by bacteria (boils, abscesses, cellulitis, impetigo)
  • infections of the women genitals following childbirth or abortion
  • Gonorrhea(sexually transmitted diseases)
  • Sepsis
  • Leptospirosis
  • Bacterial endocarditis
  • Listeriosis
  • Blood infections (septicemia or blood poisoning)
  • Dental abscess
  • Paratyphoid and typhoid fever
  • Peptic ulcers (in combination with other medicines) caused by Helicobacter pylori
  • Meningitis
  • Sepsis
  • Leptospirosis
  • Gastrointestinal infections(enterocolitis, enteric fever, cholangitis, cholecystitis)
  • Salmonellosis
  • Lyme disease

  • Mymox is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox can also be used to prevent infection when you undergo certain dental procedures. Mymox is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox belongs to a group of antibiotics called the penicillins.

    Oral Biliary tract infections

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Endocarditis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Gonorrhoea

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Otitis media

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Pneumonia

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Actinomycosis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Bronchitis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Typhoid and paratyphoid fever

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Gastroenteritis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Lyme disease

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Mouth infections

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Spleen disorders

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Urinary tract infections

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Uncomplicated gonorrhoea

    Adult: 3 g as a single dose with probenecid 1 g. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Oral Dental abscesses

    Adult: Initially, 3 g, repeat once after 8 hr. Renal impairment: Dose reduction may be required. Oral Uncomplicated acute urinary tract infections

    Adult: Initially, 3 g, repeat once after 10-12 hr. Renal impairment: Dose reduction may be required. Oral Prophylaxis of endocarditis

    Adult: 2 or 3 g as a single dose, 1 hr before dental procedure.

    Child: Single dose of 50 mg/kg. To be taken 1 hr prior to dental procedure. Max: 2 g/dose. Renal impairment: Dose reduction may be required. Oral Severe or recurrent respiratory tract infections

    Adult: 3 g bid. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Oral Otitis media

    Child: 3-10 yr: 750 mg bid for 2 days. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Oral H.pylori infection

    Adult: 0.75 or 1 g bid or 500 mg tid in combination with either metronidazole or clarithromycin and a bismuth compound or an antisecretory drug. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Parenteral Susceptible infections

    Adult: 500 mg every 8 hr via IM or slow IV inj. Severe infections: May increase to 1 g every 6 hr via slow IV inj over 3-4 minutes or infuse over 30-60 minutes.

    Child: ≤10 yr: 50-100 mg/kg daily in divided doses. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Intravenous Listerial meningitis

    Adult: 2 g every 4 hr for 10-14 days via IV infusion, to be used with other antibiotics. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr.

    Oral Biliary tract infections

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Endocarditis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Gonorrhoea

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Otitis media

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Pneumonia

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral UTI

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Actinomycosis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Bronchitis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Typhoid and Paratyphoid Fever

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Gastroenteritis

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Lyme Disease

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Mouth infections

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Spleen disorders

    Adult: 250-500 mg every 8 hr or 500-875 mg every 12 hr.

    Child: ≤10 yr: 125-250 mg every 8 hr; <40 kg: 20-40 mg/kg daily in divided doses every 8 hr. Max dose: Infant <3 mth: 30 mg/kg daily in divided doses every 12 hr. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 every 12 hr. <10 250-500 every 24 hr. Oral Uncomplicated gonorrhoea

    Adult: 3 g as a single dose with probenecid 1 g. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Oral Dental abscesses

    Adult: Initially, 3 g, repeat once after 8 hr. Renal impairment: Dose reduction may be required. Oral Uncomplicated acute urinary tract infections

    Adult: Initially, 3 g, repeat once after 10-12 hr. Renal impairment: Dose reduction may be required. Oral Endocarditis prophylaxis

    Adult: 2 or 3 g as a single dose, 1 hr before dental procedure.

    Child: Single dose of 50 mg/kg. To be taken 1 hr prior to dental procedure. Max: 2 g/dose. Renal impairment: Dose reduction may be required. Oral Severe or recurrent resp tract infections

    Adult: 3 g bid. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Oral Otitis media

    Child: 3-10 yr: 750 mg bid for 2 days. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Oral Eradication of H. pylori infection

    Adult: 0.75 or 1 g bid or 500 mg tid in combination with either metronidazole or clarithromycin and a bismuth compound or an antisecretory drug. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Intravenous Listerial meningitis

    Adult: 2 g every 4 hr for 10–14 days via IV infusion, to be used with other antibiotics. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr. Parenteral Susceptible infections

    Adult: 500 mg every 8 hr via IM or slow IV inj. Severe infections: May increase to 1 g every 6 hr via slow IV inj over 3-4 minutes or infuse over 30-60 minutes.

    Child: ≤10 yr: 50-100 mg/kg daily in divided doses. Renal impairment: Patients on haemodialysis should receive 250-500 mg every 24 hr and an additional dose during and after each dialysis session. CrCl (ml/min) Dosage Recommendation 10-30 250-500 mg every 12 hr. <10 250-500 mg every 24 hr.

    Mymox (Y.C.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Y.C.) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Y.C.) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Y.C.) belongs to a group of antibiotics called the penicillins.

    Indications:

    Adult: PO Susceptible infections 250-500 mg 8 hrly. Uncomplicated gonorrhoea W/ probenecid: 3 g as a single dose. Dental abscesses 3 g, repeat once 8 hr later. Uncomplicated acute UTI 3 g, repeat once 10-12 hr later. Prophylaxis of endocarditis 2 or 3 g as a single dose, 1 hr before dental procedure. Severe or recurrent resp tract infections 3 g twice daily. H.pylori infection W/ either metronidazole or clarithromycin and a bismuth compound or an antisecretory drug: 500 mg 3 times/day. IV/IM Susceptible infections 500 mg 8 hrly. Listerial meningitis W/ other antibiotics: 2 g 4 hrly for 10-14 days.

    Mymox (Yung Shin) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Yung Shin) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Yung Shin) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Yung Shin) belongs to a group of antibiotics called the penicillins.

    Mymox (T.F.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (T.F.) can also be used to prevent infection when you undergo certain dental procedures. Mymox (T.F.) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (T.F.) belongs to a group of antibiotics called the penicillins.

    Mymox (Tai Yu) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Tai Yu) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Tai Yu) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Tai Yu) belongs to a group of antibiotics called the penicillins.

    Mymox (S.T.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (S.T.) can also be used to prevent infection when you undergo certain dental procedures. Mymox (S.T.) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (S.T.) belongs to a group of antibiotics called the penicillins.

    Mymox is indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) strains of the designated microorganisms in the conditions listed below:Infections of the ear, nose, and throat - due to Streptococcus spp. (α- and β-hemolytic strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. Infections of the genitourinary tract - due to E. coli, P. mirabilis, or E. faecalis. Infections of the skin and skin structure - due to Streptococcus spp. (α- and β-hemolytic strains only), Staphylococcus spp., or E. coli. Infections of the lower respiratory tract - due to Streptococcus spp. (α- and β-hemolytic strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. Gonorrhea, acute uncomplicated (ano-genital and urethral infections) - due to N. gonorrhoeae (males and females).H. pylori eradication to reduce the risk of duodenal ulcer recurrence.

    Mymox (Astar) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Astar) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Astar) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Astar) belongs to a group of antibiotics called the penicillins.

    Mymox (Lin Chemical) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Lin Chemical) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Lin Chemical) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Lin Chemical) belongs to a group of antibiotics called the penicillins.

    Mymox (C.I.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (C.I.) can also be used to prevent infection when you undergo certain dental procedures. Mymox (C.I.) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (C.I.) belongs to a group of antibiotics called the penicillins.

    Mymox (Prince) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Prince) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Prince) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Prince) belongs to a group of antibiotics called the penicillins.

    Mymox (K.T.) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (K.T.) can also be used to prevent infection when you undergo certain dental procedures. Mymox (K.T.) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (K.T.) belongs to a group of antibiotics called the penicillins.

    Mymox (Kingdom) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (Kingdom) can also be used to prevent infection when you undergo certain dental procedures. Mymox (Kingdom) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (Kingdom) belongs to a group of antibiotics called the penicillins.

    Mymox (CCPC) is an antibiotic. It is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder. Mymox (CCPC) can also be used to prevent infection when you undergo certain dental procedures. Mymox (CCPC) is also used in combination with other medicines for gastric ulcers caused by a type of bacteria known as Helicobacter pylori (H. pylori). Mymox (CCPC) belongs to a group of antibiotics called the penicillins.

    Active ingredients: Amoxicillin
    Unit description, dosagePrice, USD

    List of mymox brand and generic drugs

    Mylan-Amoxicillin
    Capsules; Oral; Amoxicillin Trihydrate 500 mg
    Mymoxcil (Bangladesh)
    Navamox (Bangladesh)
    Nbmox-DC (India)
    Nbmox-DC Amoxicillin 250 mg,Dicloxacillin 250 mg. CAP / 100$ 13.89
    100's$ 13.89
    Nemoxil
    Neo Moxicilin
    Neo Vet-Cillin (Italy)
    Neo-Ampiplus (Italy)
    Neogram (Colombia)
    Neomox (Ecuador, Oman)
    Neomox 250 mg x 100's$ 17.88
    Neomox 500 mg x 100's$ 34.38
    Neomox 125 mg/5 mL x 60 mL$ 2.34
    Neomox 250 mg/5 mL x 60 mL$ 3.02
    Neotetranase (Italy)
    Nepomox (India)
    Nepomox 250mg CAP / 10$ 0.56
    Nepomox 500mg CAP / 10$ 1.02
    Nepomox 125mg P-TAB / 10$ 0.32
    250 mg x 10's$ 0.56
    500 mg x 10's$ 1.02
    125 mg x 10's$ 0.32
    Nepomox 500 mg Capsule$ 0.10
    Nepomox 250 mg Capsule$ 0.06
    NEXXIMOX (India)
    250 mg x 10's$ 0.74
    500 mg x 10's$ 1.14
    Nexximox 250 mg Capsule$ 0.07
    Nexximox 500 mg Capsule$ 0.11
    Nexximox 250mg CAP / 10$ 0.74
    Nexximox 500mg CAP / 10$ 1.14
    Nobactam (Argentina)
    Nodimox-LB (India)
    Nodimox-LB Amoxicillin 250mg,Lactobacillus 60million spores TAB / 10$ 0.67
    10's$ 0.67
    NOMCLOX (India)
    125 mg x 10's$ 0.46
    250 mg x 10's$ 0.72
    125 mg x 5 mL x 30ml$ 0.54
    500 mg x 10's$ 1.20
    Nomclox 250 mg Capsule$ 0.07
    Nomclox 500 mg Capsule$ 0.12
    Nomclox 30 ml Syrup$ 0.09
    Nomclox 125mg DT-TAB / 10$ 0.46
    Nomclox 250mg DT-TAB / 10$ 0.72
    Nomclox 125mg x 5mL DRY-SYR / 30ml$ 0.54

    Show all Mymox generic names
     
    Privacy Policy
    © 2003 - 2014 igenericdrugs.com All Rights Reserved
     
    Disclamer